SPEAR UltraDetect™ pTau 231 Biomarker Assay Kit
The SPEAR UltraDetect™ pTau 231 biomarker assay kit is highly sensitive and ideal for Alzheimer’s research using plasma samples. Requires SPEAR UltraDetect™ Reaction Kit. For research use only.
Spear Bio
Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar level from sub-microliter sample volume. Spear Bio is focused on leveraging its technology’s unprecedented sensitivity to transform protein research and early disease diagnosis.
SPEAR UltraDetect™ NF-L Biomarker Assay Kit
The SPEAR UltraDetect™ NF-L Biomarker Assay Kit lets you quantify neurofilament light with ultra-high precision, low sample volume, and a simple, wash-free workflow. Requires SPEAR UltraDetect™ Reacti...
SPEAR UltraDetect™ GFAP Biomarker Assay Kit
The SPEAR UltraDetect™ GFAP Biomarker Assay Kit is an ultra-precise, wash-free assay for glial fibrillary acidic protein, ideal for CNS and neurotrauma research. Requires SPEAR UltraDetect™ Reaction K...
SPEAR UltraDetect™ pTau 217 Biomarker Assay Kit
The SPEAR UltraDetect™ pTau 217 biomarker assay kit provides a highly specific tool for Alzheimer’s disease research, optimized for plasma samples. Requires SPEAR UltraDetect™ Reaction Kit. For resear...
Browse Products by Field
Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar level from sub-microliter sample volume. Spear Bio is focused on leveraging its technology’s unprecedented sensitivity to transform protein research and early disease diagnosis.